Patients Aged 50 Years and Older treated with Warfarin. Poisoning by, adverse effect of and underdosing of thrombolytic drugs
Conditions
Interventions
Intervention 1: Control group: In the control group, warfarin drug use is monitored in person and by referring to the warfarin dose adjustment clinic. Only the results of their PT and INR tests and th
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients need long-term treatment with warfarin. Patients who do not intend to have pre-planned surgery during the study.
Exclusion criteria
Exclusion criteria: Patients who have been treated with warfarin before hospitalization or before admission and whose INR values have been within the target range for the past three months Patients suffering from chronic diseases in acute stages such as: cancer malignancies, liver cirrhosis, respiratory failure Patients who are unable to follow the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prothrombin Time and International Normalized Ratio (PT/INR). Timepoint: Baseline and then at intervals required. Method of measurement: blood test.;Patient readmission rate. Timepoint: After the intervention. Method of measurement: Number of hospitalizations after discharge.;Side effects of warfarin use. Timepoint: After the intervention. Method of measurement: The HAS-BLED Score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahsa Boozaripoor
Shahid Beheshti University of Medical Sciences
Outcome results
None listed